Wenjian Wu

发表

Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte.

W. Bao, R. Bolli, Shelley X. L. Zhang, 2002, Journal of molecular and cellular cardiology.

Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits.

R. Bolli, Xian-Liang Tang, H. Takano, 1997, American journal of physiology. Heart and circulatory physiology.

, CXCR 4 Axis − α Derived Factor-1 − Ischemia / Reperfusion Injury : Role of the Cardiac Stromal Cell Confers Protection Against Myocardial α Derived Factor-1 −

R. Bolli, J. Mu, W. Tan, 2007 .

Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy.

R. Bolli, Xian-Liang Tang, Ding Li, 2016, Circulation research.

Preconditioning Human Cardiac Stem Cells with an HO‐1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart

R. Bolli, L. Teng, K. U. Hong, 2015, Stem cells.

Administration of Sildenafil at Reperfusion Fails to Reduce Infarct Size: Results from the CAESAR Cardioprotection Consortium (LB650)

Steven P Jones, Carlos C. Chang, R. Bolli, 2014 .

Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size

S. Khundmiri, Xian-Liang Tang, Shunichi Nakamura, 2020, Cardiovascular Drugs and Therapy.

Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy

R. Bolli, Shizuka Uchida, Xian-Liang Tang, 2018, Basic Research in Cardiology.

Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.

R. Bolli, S. Tiwari, B. Dawn, 2006, American journal of physiology. Heart and circulatory physiology.

GENE THERAPY WITH INDUCIBLE NITRIC OXIDE SYNTHASE PROVIDES LONG-TERM PROTECTION AGAINST MYOCARDIAL INFARCTION WITHOUT ADVERSE FUNCTIONAL CONSEQUENCES

R. Bolli, S. Tiwari, B. Dawn, 2005 .

Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence.

R. Bolli, Abdur Rahman Khan, Xian-Liang Tang, 2017, Journal of the American College of Cardiology.

Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose

R. Bolli, Xian-Liang Tang, Greg Hunt, 2018, Journal of the American Heart Association.

Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences

N. Chen, R. Bolli, B. Dawn, 2011, Basic Research in Cardiology.

Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS.

R. Bolli, W. Tan, Yiru Guo, 2005, American journal of physiology. Heart and circulatory physiology.

The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis.

R. Bolli, W. Tan, Yanqing Zhu, 2007, Journal of molecular and cellular cardiology.

Hypercholesterolemia Abrogates Late Preconditioning via a Tetrahydrobiopterin-Dependent Mechanism in Conscious Rabbits

Hiroshi Sato, R. Bolli, B. Dawn, 2005, Circulation.

Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury

R. Bolli, S. Ildstad, Yiming Huang, 2012, Basic Research in Cardiology.

Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models

R. Bolli, Fangping Yuan, Greg Hunt, 2011, Basic Research in Cardiology.

Downloaded from http://circres.ahajournals.org / by guest on February 21, 2013Gene Therapy With Inducible Nitric Oxide Synthase Protects Against Myocardial Infarction via a Cyclooxygenase-2–Dependent Mechanism

C. Lowenstein, R. Bolli, S. Prabhu, 2022 .

Effect of intravenous cell therapy in rats with old myocardial infarction

R. Bolli, Xian-Liang Tang, Anna M. Gumpert, 2021, Molecular and Cellular Biochemistry.

IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.

R. Bolli, B. Dawn, W. Tan, 2004, Cardiovascular research.

Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction

R. Bolli, B. Dawn, Xian-Liang Tang, 2015, Circulation. Heart failure.

Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences

N. Chen, R. Bolli, B. Dawn, 2011, Basic Research in Cardiology.

Formation of protein kinase Cε-Lck signaling modules confers cardioprotection

W. Pierce, P. Ping, T. Vondriska, 2002 .

Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.

R. Bolli, J. Mu, W. Tan, 2007, Circulation.

Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits.

R. Bolli, Xian-Liang Tang, H. Takano, 2002, American journal of physiology. Heart and circulatory physiology.

Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-&kgr;B–Dependent Pathway

R. Bolli, B. Dawn, W. Tan, 2009, Circulation.

Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor- (cid:1) B–Dependent Pathway Molecular Cardiology

R. Bolli, B. Dawn, W. Tan, 2009 .

Heme Oxygenase-1 Via a Nuclear Factor-Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection

R. Bolli, B. Dawn, W. Tan, 2009 .

Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo.

R. Bolli, B. Dawn, R. Motterlini, 2004, American journal of physiology. Heart and circulatory physiology.

Stromal Cell–Derived Factor-1 α Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1 α –CXCR4 Axis

R. Bolli, J. Mu, W. Tan, 2013 .

Stromal Cell–Derived Factor-1 (cid:1) Confers Protection Against Myocardial Ischemia/Reperfusion Injury Role of the Cardiac Stromal Cell–Derived Factor-1 (cid:1) –CXCR4 Axis

R. Bolli, J. Mu, W. Tan, 2007 .

Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection.

W. Pierce, P. Ping, T. Vondriska, 2002, The Journal of clinical investigation.

Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice

W. Bao, R. Bolli, Xian-Liang Tang, 2000, Basic Research in Cardiology.

Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.

R. Bolli, B. Dawn, W. Tan, 2004, Journal of molecular and cellular cardiology.

Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.

R. Bolli, B. Dawn, R. Motterlini, 2005, Journal of molecular and cellular cardiology.

Formation of protein kinase Cε-Lck signaling modules confers cardioprotection

W. Pierce, P. Ping, T. Vondriska, 2002 .

The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning

Steven P Jones, S. Narumiya, R. Bolli, 2012, PloS one.

Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-&kgr;B-Dependent Pathway

R. Bolli, B. Dawn, W. Tan, 2007, Circulation.

Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse.

R. Bolli, J. Mu, W. Tan, 2008, Journal of molecular and cellular cardiology.

Demonstration of an early and a late phase of ischemic preconditioning in mice.

R. Bolli, Xian-Liang Tang, Zequan Yang, 1998, American journal of physiology. Heart and circulatory physiology.

The Effect of Cardiogenic Factors on Cardiac Mesenchymal Cell Anti-Fibrogenic Paracrine Signaling and Therapeutic Performance

Xian-Liang Tang, M. Wysoczynski, Joseph B Moore Iv, 2020, Theranostics.